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Inflammation is an important component of in-
nate immunity and the host response to patho-
gens (Henneke and Golenbock, 2004). In response 
to infection with virus or bacteria, macrophages 
produce cytokines such as TNF and IL-1, which 
initiate the inflammatory response (Dinarello, 
2005). The inflammatory response must be pre-
cisely controlled at multiple levels, as uncontrolled 
inflammation does not benefit organisms but 
instead causes tissue impairment and drives 
autoimmunity, septic shock, and inflammation- 
associated malignancy (Karin and Greten, 2005).
TNF receptor–associated factors (TRAFs) 
play a central role in the TNF-, IL-1–, and LPS-
induced signaling pathways (Lee et al., 1997). 
Binding of LPS to TLR4 (Toll-like receptor 4) 
triggers the recruitment of MyD88 and IRAK1/4, 
which then recruits TRAF6 and triggers down-
stream signaling (Dong et al., 2006). Down-
stream of TRAF6, TAK1 (TGF-–activated 
kinase 1) and the adaptor proteins TAB2 and 
TAB3 mediate the activation of the IB kinase 
(IKK) complex (Sato et al., 2005). TAK1 has 
also been reported to be important for TNF-
mediated NF-B activation (Takaesu et al., 
2003). Binding of IL-1 to the IL-1R also trig-
gers the recruitment of the adaptor protein 
MyD88 to the receptor. MyD88 then recruits 
the kinases IRAK1 and IRAK4, which play an 
essential role in the recruitment of TRAF6, 
triggering its oligomerization and autoubiqui-
tination via Lys 63 (K63)–linked ubiquitin 
chains (Deng et al., 2000). Binding of TNF to 
TNF-R1 results in the recruitment of the 
adaptor protein TRADD (TNF receptor type 1– 
associated death domain protein), which 
subsequently recruits a signaling complex con-
sisting of TRAF2, TRAF5, and RIP1 (Tada 
et al., 2001). TRAF2 or RIP1 then plays a role 
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The intensity and duration of macrophage-mediated inflammatory responses are controlled 
by proteins that modulate inflammatory signaling pathways. MCPIP1 (monocyte chemotac-
tic protein–induced protein 1), a recently identified CCCH Zn finger–containing protein, 
plays an essential role in controlling macrophage-mediated inflammatory responses. How-
ever, its mechanism of action is poorly understood. In this study, we show that MCPIP1 
negatively regulates c-Jun N-terminal kinase (JNK) and NF-B activity by removing ubiq-
uitin moieties from proteins, including TRAF2, TRAF3, and TRAF6. MCPIP1-deficient mice 
spontaneously developed fatal inflammatory syndrome. Macrophages and splenocytes from 
MCPIP1/ mice showed elevated expression of inflammatory gene expression, increased 
JNK and IB kinase activation, and increased polyubiquitination of TNF receptor–associated 
factors. In vitro assays directly demonstrated the deubiquitinating activity of purified 
MCPIP1. Sequence analysis together with serial mutagenesis defined a deubiquitinating 
enzyme domain and a ubiquitin association domain in MCPIP1. Our results indicate that 
MCPIP1 is a critical modulator of inflammatory signaling.
© 2010 Liang et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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RESULTS
Disruption of MCPIP1 leads to severe inflammatory response 
and premature death in mice
Previously, we have identified MCPIP1 as a negative regula-
tor of LPS- and cytokine-induced macrophage activation 
in vitro probably by antagonizing the NF-B signaling pathway 
(Liang et al., 2008b). To further investigate the physiological 
function of MCPIP1 in vivo, we generated Mcpip1/ mice 
by homologous recombination in embryonic stem cells from 
C57BL/6 background mice. We targeted mouse Mcpip1 
exons 4 and 5 and most of 6 with a LacZ-neomycin cassette 
in embryonic stem cells established from C57BL/6 mice and 
established Mcpip1/ mice in pure C57BL/6 background 
(Fig. 1 a). We confirmed homologous recombination of the 
Mcpip1 locus by Southern blot analysis (unpublished data). 
The lack of MCPIP1 protein in Mcpip1/ mice was con-
firmed by immunoblotting (Fig. 1 b). Mcpip1/ mice were 
born from interbred Mcpip1+/ mice at the expected Mende-
lian ratios and looked normal at birth. Similar to the findings 
in a recent study (Matsushita et al., 2009), Mcpip1/ mice 
showed growth retardation after weaning (Fig. 1 c), severe 
splenomegaly (Fig. 1 d, top), and lymphadenopathy (Fig. 1 d, 
bottom) and died prematurely (Fig. 1 e). Meanwhile, serum 
TNF and MCP-1 levels in Mcpip1/ mice were >2.5 times 
of those in Mcpip1+/+ mice (Fig. 1 f). To examine the function 
of MCPIP1 in macrophages, we isolated BM-derived macro-
phages (BMDMs) from Mcpip1+/+ and Mcpip1/ mice. 
MCPIP1-deficient BMDMs secreted a greater amount of 
proinflammatory cytokines TNF, IL-1, IL-6, or MCP-1 
both in normal culture conditions and in response to LPS 
stimulation as compared with WT BMDMs (Fig. 1 g). Real-
time RT-PCR showed that the mRNA levels of inflamma-
tory cytokines, including TNF, IL-6, and IL-1, were also 
increased in BMDMs from Mcpip1/ mice in response to 
LPS stimulation (Fig. 1 h). As RNA blotting detected abun-
dant mRNA of Mcpip1 in spleen, thymus, lung, and intestine 
(Fig. S1), we also isolated the total RNA from these tissues of 
both Mcpip1+/+ and Mcpip1/ mice. As expected, the mRNA 
expression of inflammatory cytokines, including TNF, IL-1, 
IL-6, and iNOS (inducible nitric oxide synthase), was signifi-
cantly up-regulated in the intestine, lung, and thymus from 
Mcpip1/ mice compared with Mcpip1+/+ mice (Fig. S2). 
Collectively, these results further indicate that MCPIP1 is a 
critical modulator of macrophage inflammation in vivo and 
may play a key role in controlling inflammatory response and 
immune homeostasis.
Effect of MCPIP1 on LPS or IL-1–induced JNK and NF-B 
signaling activation
To understand the mechanisms underlying the inflammatory 
phenotypes of Mcpip1-null mice, we first isolated the protein 
extracts of lungs from both Mcpip1+/+ and Mcpip1/ mice. As 
shown in Fig. 2 a, the JNK phosphorylation was markedly in-
creased in lung tissue from Mcpip1/ mice compared with 
that from Mcpip1+/+ mice. Phospho–IKK- and phospho-
IB were moderately increased, whereas total IB protein 
in the recruitment of the IKK complex to TNF-R1, leading 
to oligomerization and activation. In addition to NF-B acti-
vation, TNF, IL-1, and LPS are potent activators of c-Jun 
N-terminal kinase (JNK), which regulates the activation of 
AP-1 transcription factors, including c-Jun and ATF-2 (Song 
et al., 1997).
JNK and NF-B signaling mediate a wide spectrum of 
cellular responses, including infections, inflammation, and 
apoptosis (Muzio et al., 1998). Inappropriate regulation of 
JNK and NF-B signaling is involved in a wide range of 
human diseases, including cancer, neurodegenerative disor-
ders, arthritis, asthma, and chronic inflammation (Karin and 
Greten, 2005). Thus, JNK and NF-B activation must be 
tightly regulated to maintain transient activation to prevent 
inflammation-induced tissue damage or malignancy associ-
ated with persistent JNK and NF-B activation. Ubiquitina-
tion plays important regulatory roles in several steps of JNK 
and NF-B signaling events and thus is an important target 
for several negative regulators of JNK and NF-B. The cyl-
indromatosis tumor suppressor CYLD has been shown to 
inhibit both JNK and NF-B signaling mediated by TNF, 
LPS, CD40, and IL-1 by cleaving K63-linked ubiquitin 
chains on TRAF2, TRAF6, and IKK- (Kovalenko et al., 
2003; Regamey et al., 2003; Trompouki et al., 2003; Reiley 
et al., 2004). Another deubiquitinating enzyme (DUB) that 
is an important regulator of NF-B is A20, which is a tran-
scriptional target of NF-B (Wertz et al., 2004). A20-deficient 
mice develop severe inflammation and cachexia and die pre-
maturely (Lee et al., 2000).
MCPIP1 (monocyte chemotactic protein [MCP]–induced 
protein 1; also known as ZC3H12A) is a recently identified 
gene in human peripheral blood monocytes treated with 
MCP-1 (Zhou et al., 2006; Liang et al., 2008b). The gene 
undergoes rapid and potent transcription induction upon 
stimulation with proinflammatory molecules such as TNF, 
MCP-1, IL-1, and LPS (Liang et al., 2008a,b; Matsushita 
et al., 2009; Skalniak et al., 2009; Kasza et al., 2010). Further 
studies showed that MCPIP1 plays an important role in 
both physiological and pathological processes related to in-
flammation. In the experiments on cultured cells, MCPIP1 
was proved to be a negative regulator of macrophage activa-
tion (Liang et al., 2008b). In a recent study on mice, 
MCPIP1 deficiency led to a complex phenotype including 
severe anemia, autoimmune response, and severe inflamma-
tory response, and most mice died within 12 wk of birth 
(Matsushita et al., 2009). The underlying mechanism of ac-
tion of MCPIP1 is poorly understood, but it was suggested 
that it may control messenger RNA (mRNA) stability of 
a set of inflammatory genes by functioning as an RNase 
(Matsushita et al., 2009). In this study, we report that 
MCPIP1 acts as a deubiquitinase to negatively regulate JNK 
and NF-B signaling by targeting TRAFs. These results 
suggest that MCPIP1 may critically control inflammation 
and immune response by multiple mechanisms and would 
be a potential therapeutic target for treatment of human in-
flammatory diseases.
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Raw264.7 cells. Transfected cells were stimulated by 100 ng/ml 
LPS for 0, 5, 15, and 30 min after 24 h of quiescence. The ac-
tivation of signaling proteins in the JNK and NF-B signaling 
pathways was detected by immunoblotting with phospho-
specific antibodies. As shown in Fig. 2 c, MCPIP1 expression 
completely blocked LPS-induced JNK phosphorylation and 
partially blocked ERK1/2, p38, and IKK- phosphorylation. 
These changes were not caused by protein degradation because 
JNK, ERK1/2, p38, and IKK- protein levels were not affected 
by MCPIP1 overexpression. These results suggest that MCPIP1 
expression significantly inhibits LPS-induced JNK activation 
but moderately affects ERK1/2, p38, and IKK activation. 
was decreased in the lung from Mcpip1/ mice compared 
with those from Mcpip1+/+ mice. These results suggested that 
both JNK and NF-B signaling were constitutively activated 
in the lung of Mcpip1/ mice. Second, we examined LPS-
induced JNK and NF-B signaling activation in BMDMs 
from Mcpip1+/+ or Mcpip1/ mice. As shown in Fig. 2 b, 
LPS-induced phosphorylation of JNK, ERK1/2, and IKK- 
was significantly enhanced in Mcpip1/ BMDMs compared 
with Mcpip1+/+ BMDMs. These results suggest that Mcpip1 is 
essential for the down-regulation of JNK and NF-B activa-
tion upon LPS stimulation. To further confirm the effect of 
MCPIP1 on LPS-stimulated JNK and NF-B signaling acti-
vation, we transfected MCPIP1 and control vectors into 
Figure 1. Disruption of MCPIP1 leads to severe inflammatory response and premature death in mice. (a) The structure of the mouse Mcpip1 
gene is shown. The targeting strategy deleted exons 4 and 5 and most of 6, which encode the most part of the MCPIP1 protein, including the ZF and Pro 
domains. (b) Proteins extracted from the intestine, lung, and spleen of mice were analyzed by immunoblotting with MCPIP1-specific antibody. The same 
membrane was probed with antiactin to show equal loading. The experiment was performed on three independent sets of animals. (c and d) Gross  
appearance of Mcpip1+/+ and Mcpip1/ mice (6–8-wk-old male; c), as well as spleens (d, top) and LNs (d, bottom) from these mice. The ruler (left margin) 
indicates size in centimeters. Three independent sets of animals showed similar results. (e) Survival rate of Mcpip1+/+ and Mcpip1/ mice (n = 19).  
(f) ELISA was used to measure serum cytokine levels in WT and KO mice. Data are presented as mean ± SD (n = 6; *, P < 0.05; **, P < 0.01 vs. WT group).  
(g) BMDMs from WT (open bars) and KO (closed bars) mice were stimulated with PBS or 100 ng/ml LPS for 5 h. ELISA was used to measure cytokine levels 
in cultured medium. Data are presented as mean ± SD (n = 3; *, P < 0.05; **, P < 0.01 vs. WT group). Results are representative of two independent experi-
ments. (h) Total RNA isolated from BMDMs stimulated with LPS for the indicated time periods was reverse transcribed and analyzed by QPCR with gene-
specific primers as indicated. Data are presented as mean ± SD (n = 3). Student’s t test was performed. The experiment was performed on two 
independent sets of animals with triplicate measurements.
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However, Mcpip1 deficiency did not significantly 
affect the activation of ERK1/2 and IKK-. To 
further confirm the effect of MCPIP1 on IL-1–
stimulated JNK and NF-B signaling activation, 
we transfected MCPIP1 and control vectors into 
HepG2 cells, a cell type which is easier for transfec-
tion and responds efficiently to IL-1 stimulation. 
Consistently, MCPIP1 expression significantly 
suppressed IL-1–induced JNK phosphorylation 
but did not affect ERK1/2, p38, and IKK- 
phosphorylation. These results suggest that MCPIP1 
is essential to down-regulate IL-1–induced 
JNK signaling but not critical in IL-1–induced 
ERK1/2, p38, and NF-B signaling.
MCPIP1 inhibits NF-B– and AP-1–  
but not STAT-dependent gene activation
Next, we examined the effect of MCPIP1 on 
NF-B–, AP-1–, or STAT-dependent gene acti-
vation. Raw264.7 cells were transiently trans-
fected with a luciferase reporter construct, NF-B–TK-Luc, 
AP-1–TK-Luc, or GAS-TK-Luc, together with increasing 
doses of hemagglutinin (HA)-tagged MCPIP1. After over-
night of quiescence, cells were either left untreated or treated 
with LPS or TNF or IFN- plus LPS for 24 h, followed by 
luciferase assays. As shown in Fig. 3 (a and b), MCPIP1 over-
expression did not significantly affect the basal activity of 
NF-B reporter and AP-1 reporter. However, overexpression 
of MCPIP1 significantly inhibited LPS-induced NF-B re-
porter activation and TNF-induced AP-1 reporter activation 
Consistently, MCPIP1 expression also reduced LPS-induced 
p65 nuclear translocation in Raw264.7 cells.
To examine the function of MCPIP1 in IL-1R signaling, 
we analyzed the effect of Mcpip1 deficiency on IL-1–
stimulated activation of JNK and NF-B signaling in primary 
mouse embryonic fibroblasts (MEFs), a cell type which re-
sponds efficiently to IL-1 stimulation. As shown in Fig. 2 d, 
Mcpip1-deficient MEFs showed increased activation of JNK 
in response to IL-1 stimulation, suggesting that MCPIP1 is 
essential to down-regulate IL-1–induced JNK activation. 
Figure 2. Effect of MCPIP1 on LPS- and IL-1–
induced JNK and NF-B activation. (a) Proteins ex-
tracted from the lung of three pairs of Mcpip1+/+ and 
Mcpip1/ mice were analyzed by immunoblot with the 
indicated antibodies. Results are representative of three 
independent experiments. (b) BMDMs from Mcpip1/ or 
Mcpip1+/+ mice were quiescent for 16 h and then stimu-
lated with 100 ng/ml LPS for the indicated time periods. 
WCEs were subjected to immunoblot analysis with anti-
bodies as indicated. Similar results were seen in three inde-
pendent experiments. (c) Raw264.7 cells were transfected 
with pcDNA3 (vector) or pHA-MCPIP1. After 24 h, the 
transfected cells were quiescent for 16 h and then stimu-
lated with 100 ng/ml LPS for the indicated time periods. 
WCEs were subjected to immunoblot analysis with anti-
bodies as indicated. Nuclear fractions (Nuc.) were prepared 
and subjected to immunoblot analysis using p65-specific 
antibody. Results are representative of at least three inde-
pendent experiments. (d) MEFs from Mcpip1/ or 
Mcpip1+/+ mice were quiescent for 16 h and stimulated 
with 10 ng/ml IL-1 for the indicated time periods. WCEs 
were subjected to immunoblot analysis with antibodies as 
indicated. (e) HepG2 cells were transfected with pcDNA3 
(vector) or pHA-MCPIP1. After 24 h, the transfected cells 
were quiescent for 16 h and then stimulated with 10 ng/ml 
IL-1 for the indicated times. WCEs were subjected to 
immunoblot analysis with antibodies as indicated.
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NF-B and JNK–AP-1 signaling pathways but does not 
affect the JAK–STAT signaling pathway.
NF-B and AP-1 individually or coordinately regulate a 
large set of inflammatory gene expressions. To examine the 
whole gene expression changes caused by MCPIP1 expres-
sion in an unbiased way, we performed microarray analysis. 
A macrophage cell line Raw264.7 was transfected with GFP 
or MCPIP1-GFP constructs. These cells were treated with or 
without LPS for 8 h before mRNA harvest. Overall, LPS 
treatment induced 1,783 genes by more than threefold com-
pared with the untreated cells. Among the 1,783 of LPS-
induced genes, 30% of them were affected by overexpression 
of MCPIP1 (Fig. 3 d). Among the MCPIP1-affected genes, 
85% of the genes were repressed by MCPIP1, and 15% of 
the genes were up-regulated by MCPIP1. The 26 genes up- 
regulated by >10-fold in LPS-treated cells were selected and 
shown in Fig. 3 e as a heat map. Consistent with our previous 
results (Liang et al., 2008b), the inflammatory genes TNF, 
IL-1, IL-6, and MCP-1, whose transcription is controlled by 
NF-B and JNK signaling, were significantly repressed by 
MCPIP1. Overexpression of MCPIP1 was confirmed by 
immunoblotting with MCPIP1 antibody (Fig. 3 e, bottom). 
These results further support the idea that MCPIP1 may con-
trol a set of the inflammatory gene expressions and prevent 
inflammatory responses in vivo.
MCPIP1 acts as a deubiquitinase
Recent studies have identified a critical role for ubiquitina-
tion in JNK and NF-B signaling (for review see Skaug et al., 
2009). To understand how MCPIP1 regulates JNK and NF-B 
signaling, we first tested the effect of MCPIP1 expression 
on global protein ubiquitination. To facilitate the detection of 
ubiquitin conjugates, HEK293 cells were transfected with 
HA-tagged ubiquitin and MCPIP1 or tristetraprolin (TTP), 
another well-studied CCCH Zn finger protein. Immuno-
blotting of whole cell lysates with HA antibody revealed that 
cells expressing MCPIP1 contained far fewer ubiquitinated 
proteins than cells not expressing MCPIP1 (Fig. 4 a). Interest-
ingly, TTP also reduced protein ubiquitination, although less 
potently than MCPIP1. These results indicate that MCPIP1 
promotes deubiquitination, although it remains uncertain 
whether MCPIP1 has intrinsic deubiquitinating activity or 
regulates ubiquitination indirectly via other cellular proteins. 
To determine whether MCPIP1 has deubiquitinating activity, 
we purified Flag-tagged MCPIP1 from HEK293 cells. The 
purity of the purified protein was confirmed by Coomassie 
brilliant blue staining and immunoblotting analysis (Fig. 4 b). 
To test whether MCPIP1 cleaves K48- or K63-linked poly-
ubiquitin, we incubated MCPIP1 with K48- or K63-linked 
pentaubiquitin. Isopeptidase T (IsoT), a well-known deubiq-
uitinase (Hadari et al., 1992), was also included as a positive 
control. As shown in Fig. 4 c, MCPIP1 cleaved K48-linked 
polyubiquitin chain into monomers, as did IsoT. MCPIP1 
cleaved K63-linked polyubiquitin chain into different oligo-
mers, which suggests incomplete cleavage. To exclude the 
possibility that this deubiquitinating activity is caused by trace 
in a concentration-dependent manner. MCPIP1 expression 
did not affect LPS- and IFN-–induced STAT-dependent gene 
activation (Fig. 3 c). The overexpression of MCPIP1 in the trans-
fected cells was confirmed by immunoblotting with HA anti-
body (Fig. 3 c, bottom). These results further support the idea 
that MCPIP1 selectively represses LPS- and cytokine-initiated 
Figure 3. Overexpression of MCPIP1 inhibits NF-B and AP-1 but 
not STAT activation. (a–c) Raw264.7 cells were cotransfected AP-1– 
TK-Luc (a), NF-B–TK-Luc (b), or GAS-TK-Luc (c) with increasing amounts of 
pHA-MCPIP1 (0, 25, 50, and 100 ng/well, as indicated by wedges) using 
Fugene6 (Roche). After quiescence for 16 h, cells were treated with or 
without 10 ng/ml TNF (a), 100 ng/ml LPS (b), or IFN- plus LPS (c).  
Reporter gene activity was analyzed 24 h later. The data are presented as 
mean ± SD (n = 4; *, P < 0.01 vs. stimulated without MCPIP1 transfection 
group). Analysis of variance with Bonferroni correction was performed. 
Results are representative of at least three independent experiments. 
Immunoblotting shows expression of HA-MCPIP1. -Actin served as a 
loading control. (d) Raw264.7 cells were transfected with pEGFP-N1 or 
pMCPIP1-GFP plasmids. 16 h later, the transfected cells were treated with 
or without 1 mg/ml LPS for 8 h. mRNA was labeled and hybridized to the 
44K Agilent Mouse Oligo Microarray. 30% of LPS-induced genes were 
affected by the expression of MCPIP1. (e) 26 selected genes that are in-
duced by LPS >10-fold (some unaffected by MCPIP1 and others affected 
by MCPIP1) were clustered and presented as a heat map. Red is repre-
sented as high expression, whereas black means low expression. The ex-
pression of MCPIP1-GFP (93 kD) was detected by immunoblotting with 
anti-MCPIP1 and shown at the bottom.
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linear diubiquitins. Further experiments confirmed that 
MCPIP1 cleaved K63-linked octaubiquitin chains in dose- 
and time-dependent manners (Fig. 4 f). Furthermore, we ob-
served that the activity of MCPIP1 to cleave polyubiquitin 
was completely blocked by N-ethylmaleimide (NEM), a Cys 
protease inhibitor (Fig. 4 g). Interestingly, the deubiquitinat-
ing activity of MCPIP1 was also completely abolished by 
Zn2+ and Mn2+ but was not affected by Mg2+, Ca2+, and 
EDTA (Fig. 4 h). To further quantitatively assess the deubiq-
uitinating activity for MCPIP1, we incubated purified 
DUB contamination from 3xFlag elution buffer or immuno-
precipitation procedures, we incubated hexaubiquitin chain 
with 3xFlag elution buffer, immunoprecipitants from empty 
vector–transfected cells, or Flag-p53. No cleavage was de-
tected in these reactions (Fig. 4 d). Next, we incubated Flag-
MCPIP1 protein with K63-linked polyubiquitin chains of 
different lengths, followed by immunoblotting detection. As 
shown in Fig. 4 e, MCPIP1 cleaved polyubiquitin with a pref-
erence for high molecular polyubiquitin chains like hexa-
ubiquitin or octaubiquitin. It showed little cleavage toward the 
Figure 4. MCPIP1 acts as a deubiquitinase. (a) HEK293 cells were cotransfected with HA-ubiquitin (Ub) and/or MCPIP1-GFP and/or Flag-TTP. 36 h later, 
the ubiquitinated proteins in denatured cell lysates were detected by immunoblotting (IB) with HA-specific antibody. The expression of MCPIP1-GFP, Flag-TTP, 
and actin was also detected by immunoblotting with MCPIP1, Flag, and actin-specific antibodies. Results are representative of at least three independent 
experiments. (b) Flag-tagged MCPIP1 was immunoprecipitated from transfected HEK293 cells. The purified protein was examined by Coomassie blue staining 
(Coomas.) and immunoblotting using Flag-specific antibody. (c) 1 µg of purified Flag-MCPIP1 was incubated with K63- or K48-linked pentaubiquitin chains 
(Ub5) at 37°C for 16 h. Reactions were analyzed by immunoblotting with ubiquitin-specific antibody. Recombinant IsoT was used as a positive control. The 
blot below the dashed lines had a longer exposure time than the blot above the dashed lines. Long exposure means 2–5 min exposure of the same film.  
(d) Flag-MCPIP1, 3xFlag elution buffer, immunoprecipitants from empty vector–transfected cells, or Flag-p53 was incubated with K63-linked Ub6 at 37°C for 
16 h. Reactions were analyzed by immunoblotting with ubiquitin-specific antibody. HMUb, high molecular weight ubiquitin. (e) In vitro deubiquitination  
assays using purified Flag-MCPIP1 showing cleavage of high molecular K63-linked polyubiquitin chains (Ub5–8) but not low molecular polyubiquitin chains  
(Ub2–4) or linear Ub2. (f) In vitro deubiquitination showing that MCPIP1 cleaved Ub8 in time- and dose-dependent manners. (g and h) MCPIP1 deubiquitinase 
activity was assessed in the presence of the Cys protease inhibitor NEM, 10 mmol/l Zn2+, 10 mmol/l Mn2+, 50 mmol/l EDTA, 10 mmol/l Mg2+, or 10 mmol/l Ca2+. 
Data in b–h are representative of at least three independent experiments. (i) 0.5, 1, and 2 µg (indicated by wedge) of purified Flag-MCPIP1 was incubated with 
80 µM ubiquitin-AFC at 23°C for 5 min. The protease activity was determined by the release of fluorescent AFC (ex: 400 nm, em: 505 nm). 1 µg IsoT was used 
as a positive control. Values were represented as relative fluorescent units (RFU; mean ± SD; n = 3; *, P < 0.001 vs. none group). Two-way analysis of variance 
with Bonferroni correction was performed. The top shows a fluorescent image of the reactions in a 96-well plate. Results are representative of two indepen-
dent experiments. (j) The global cellular ubiquitinated proteins in the splenocytes from Mcpip1+/+ and Mcpip1/ mice were detected by immunoblotting with 
ubiquitin-specific antibody. Actin was detected and served as a loading control. Three independent experiments showed similar results.
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IB in the immunoprecipitates was further detected by 
immunoblotting with HA antibody. As shown in Fig. 5 c, 
MCPIP1 expression also dramatically decreased IB ubiq-
uitination. To further examine whether MCPIP1 physiologi-
cally regulates TRAF ubiquitination in vivo, TRAF2 in the 
spleen of Mcpip1/ and Mcpip1+/+ mice was immunoprecip-
itated by TRAF2 antibody. The ubiquitinated TRAF2 in the 
immunoprecipitates was detected by immunoblotting with 
ubiquitin antibody. As shown in Fig. 5 d, TRAF2 was consti-
tutively ubiquitinated in Mcpip1/ mice but not in Mcpip1+/+ 
mice (Fig. 5 d). To further examine the effect of Mcpip1 defi-
ciency on TRAF ubiquitination in response to LPS stimulation, 
we isolated splenocytes from Mcpip1+/+ mice and Mcpip1/ 
mice. The in vitro cultured splenocytes were stimulated with 
100 ng/ml LPS for 30 min. TRAF2, TRAF3, TRAF6, and 
RIP were immunoprecipitated with the respective individual 
antibody. The polyubiquitinated TRAF2, TRAF3, TRAF6, and 
RIP in the immunoprecipitates were detected by immuno-
blotting with ubiquitin antibody. As shown in Fig. 5 e, 
Mcpip1 deficiency led to a drastic increase in both basal and 
LPS-induced ubiquitination of TRAF2, TRAF3, and TRAF6 
but not RIP in splenocytes. To further examine whether 
MCPIP1 directly cleaves polyubiquitin chain from ubiqui-
tinated TRAF2 and TRAF3, we transfected Flag-TRAF2 
or Flag-TRAF3 with HA-ubiquitin into HEK293 cells. 
The transfected cells were stimulated with TNF for 15 min 
before harvest. The cellular ubiquitinated TRAF2 was puri-
fied by anti-Flag gel and washed with 3xFlag buffer and 
incubated with 0, 0.5, and 2 µg Flag-MCPIP1, followed by 
immunoblotting with HA antibody. As shown in Fig. 5 f, the 
ubiquitin moieties on TRAF2 can be removed by MCPIP1 
in a dose-dependent manner. Similarly, the ubiquitin moi-
eties on TRAF3 can also be removed directly by MCPIP1 
(Fig. 5 g). Flag–bacterial alkaline phosphatase (BAP) and IsoT 
were also included in this assay to serve as negative and 
positive control, respectively (Fig. 5 h). Collectively, these 
results suggest that MCPIP1 deubiquitinase may directly 
target the TRAF family, by which it regulates JNK and 
NF-B signaling.
MCPIP1 contains a novel DUB domain
The aforementioned results strongly suggest that MCPIP1 
functions as a deubiquitinase to control the inflammatory 
signal pathways by removing the polyubiquitin moieties from 
ubiquitinated TRAFs. DUBs are proteases that cleave ubiqui-
tin chains from protein substrates or their degradation rem-
nants. The human genome encodes 100 DUBs. On the basis 
of their domain structures, DUBs can be divided into five 
families (Reyes-Turcu et al., 2009). Four are Cys proteases, 
including ubiquitin-specific proteases, ubiquitin C-terminal 
hydrolases (UCHs), otubain proteases, and Machado-Joseph 
disease proteases. The other is a family of metalloproteases. 
To determine whether MCPIP1 belongs to any of the five 
families, we aligned the MCPIP1 protein sequences with the 
five DUB domains. There is no essential sequence similarity 
MCPIP1 with ubiquitin–7-amino-4-trifluoromethylcouma-
rin (AFC) in an in vitro deubiquitination assay. Purified 
MCPIP1 cleaved ubiquitin-AFC in a dose-dependent manner 
with less potency compared with IsoT (Fig. 4 i). Moreover, 
the global ubiquitinated protein level in the splenocytes from 
Mcpip1/ mice was much higher than that from Mcpip1+/+ 
mice (Fig. 4 j). Collectively, these results indicate that MCPIP1 
has intrinsic deubiquitinating activity and suggest that MCPIP1 
may regulate JNK and NF-B signaling through deubiqui-
tination in vivo.
MCPIP1 deubiquitinase targets to TRAFs
TRAFs have been shown to function as ubiquitin ligases that 
catalyze the synthesis of K63-linked polyubiquitin chains. 
However, this type of ubiquitination, which occurs early during 
a cellular response and does not target protein degradation, 
is important for signal transduction (Lomaga et al., 1999; 
Lamothe et al., 2007). Stimulus-dependent autoubiquitination 
of TRAF2 and TRAF6 activates the TAK1, which is criti-
cal in the activation of NF-B and MAPK (mitogen- 
activated protein kinase). To examine whether MCPIP1 
targets the key components in the JNK and NF-B signaling 
pathways, we transfected HA-ubiquitin with MCPIP1-GFP 
or Flag-TTP into HEK293 cells. After 2 h of TNF treatment, 
both TRAF2 and TRAF6 in the denatured cell lysates were 
immunoprecipitated by TRAF2 or TRAF6 antibodies. The 
ubiquitinated TRAF2 or TRAF6 in the immunoprecipitates 
was further detected by immunoblotting with HA antibody. 
As shown in Fig. 5 a, both TRAF2 and TRAF6 were ubiqui-
tinated upon HA-ubiquitin overexpression. Intriguingly, 
MCPIP1 expression markedly decreased TRAF2 and TRAF6 
ubiquitination. TTP, another CCCH Zn finger protein, did 
not affect TRAF2 ubiquitination but seemed to also reduce 
TRAF6 ubiquitination. We also observed the effect of 
MCPIP1 on the ubiquitination of receptor-interacting pro-
tein (RIP) and NF-B essential modulator (NEMO). Inter-
estingly, MCPIP1 similarly decreased the RIP ubiquitination 
but showed less effect on NEMO ubiquitination. Because 
RIP ubiquitination is dependent on TRAF2 signaling, the ef-
fect of MCPIP1 on RIP ubiquitination may be indirect. 
To further confirm the effect of MCPIP1 on TRAF ubiqui-
tination, we cotransfected Flag-TRAF2 or Flag-TRAF3 with 
HA-ubiquitin into HEK293 cells. The ubiquitinated TRAF2 
or TRAF3 in the denatured cell lysates was immunoprecipi-
tated by Flag antibody and further detected by immunoblot-
ting with HA antibody. Polyubiquitination of both proteins 
was indeed observed. Transfection of MCPIP1 together with 
TRAF2 or TRAF3 resulted in a drastic decrease in the ubiq-
uitinated forms of the two proteins (Fig. 5 b). Next, we tested 
whether MCPIP1 also affects the K48-linked ubiquitination 
of IB. We transfected HA-ubiquitin with Flag-MCPIP1 
into HEK293 cells. After 24 h, the transfected cells were 
treated with TNF and MG132 for 2 h to prevent the deg-
radation of cellular proteins mediated by K48-linked poly-
ubiquitin chain. IB in the denatured cell lysates was 
immunoprecipitated by IB antibody. The ubiquitinated 
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between MCPIP1 and the five DUB domains except remote 
homology with UCH domain (27%), which suggests that 
MCPIP1 may contain a novel DUB domain. To find the con-
served domains on MCPIP1 protein, we analyzed MCPIP1 
Figure 5. MCPIP1 deubiquitinase targets TRAFs. (a) HEK293 cells were cotransfected with HA-tagged human WT ubiquitin (Ub) with or without 
MCPIP1-GFP or Flag-TTP. 24 h later, the cells were treated with TNF for 2 h. TRAF2, TRAF6, RIP, and NEMO were immunoprecipitated (IP) and immuno-
blotted (IB) using anti-HA, anti-TRAF2, anti-TRAF6, anti-RIP, or anti-NEMO as indicated. MCPIP1 expression in WCEs was detected using anti-MCPIP1.  
IgH, Ig heavy chain. (b) HEK293 cells were cotransfected with HA-ubiquitin, Flag-TRAF2, or Flag-TRAF3 with or without MCPIP1-GFP. 24 h later, the cells were 
treated with TNF for 2 h. Lysates were subjected to immunoprecipitation and immunoblot with the indicated antibodies. MCPIP1 expression in WCEs was 
detected using anti-MCPIP1. (c) HEK293 cells were cotransfected with HA-ubiquitin with or without MCPIP1-GFP. After 2 h of TNF and MG132 treatment, 
the cells were harvested and subjected to immunoprecipitation using IB-specific antibody. The immunoprecipitates were examined by immunoblot 
with anti-HA and anti-IB. Data in a–c are representative of at least two independent experiments. (d) Endogenous TRAF2 in the spleens from Mcpip1+/+ 
and Mcpip1/ mice was immunoprecipitated with anti-TRAF2, followed by immunoblotting with ubiquitin and TRAF2-specific antibodies. Results are 
representative of two independent experiments with similar results. (e) Splenocytes from Mcpip1+/+ and Mcpip1/ mice were stimulated with 100 ng/ml 
LPS for 30 min. The endogenous TRAF2, TRAF3, TRAF6, and RIP were immunoprecipitated, followed by immunoblotting with antiubiquitin. Results are 
representative of two independent experiments with similar results. (f and g) Ubiquitinated purified TRAF2 and TRAF3 were incubated with Flag-MCPIP1 
at 37°C for 4 h and analyzed by immunoblotting with anti-HA and anti-Flag. The ubiquitin was tagged with HA. Two independent experiments showed 
similar results. (h) HEK293 cells were cotransfected with Flag-TRAF2 with or without HA-ubiquitin. Flag-TRAF2 protein in cell lysates was purified by anti-
Flag matrix and incubated with 3xFlag buffer only, 0.5 µg Flag-BAP, or 0.5 µg IsoT at 37°C for 4 h and analyzed by immunoblotting with anti-HA.
sequence by several programs such as Pfam and SMART. 
At the N terminus, MCPIP1 contains a ubiquitin association 
domain (UBA). In the middle, there is a conserved CCCH-
type Zn finger domain (ZF). At the C terminus, MCPIP1 
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C157A, and C306R still efficiently digested the transcript. 
To further confirm that the repressor effect of MCPIP1 on 
inflammatory signaling is dependent on its DUB activity but 
not its RNase activity, HEK293 cells were transfected with 
control vector, MCPIP1, or its C157A mutant. The transfected 
cells were quiescent overnight and stimulated with TNF for 0, 
15, and 30 min. As shown in Fig. 6 i, MCPIP1 significantly 
suppressed TNF-induced JNK phosphorylation as it did in 
other cell lines. C157A mutant, which lost DUB activity but 
maintained RNase activity, did not suppress TNF-induced 
JNK phosphorylation. Furthermore, ectopic expression of 
MCPIP1 in Mcpip1/ MEFs reduced LPS-induced TNF 
and MCP-1 release; however, C157A mutant lost the repres-
sor effect (Fig. 6 j). These results suggest that inhibition of 
MCPIP1 on JNK and NF-B signaling activation may be 
dependent on its DUB activity but not its RNase activity.
MCPIP1 interacts with ubiquitin through its UBA
Ubiquitin-binding domains such as the UBA and ubiquitin-
interacting motif can influence various cellular events through 
binding to ubiquitinated proteins, but the function of ubiqui-
tin-binding domains in the deubiquitination reaction remains 
to be elucidated. As shown in Fig. 6 a, MCPIP1 has a putative 
UBA at the N terminus. The consensus sequence of UBA in 
MCPIP1 is conserved from fly to human (Fig. 7 a). To assess 
whether MCPIP1 directly binds to ubiquitin through these 
putative UBAs, HEK293 cells were transfected with MCPIP1, 
the N-terminal truncated form of MCPIP1 without UBA 
(MCPIP1N), or the C-terminal truncated form of MCPIP1 
(MCPIP1C; Fig. 7 b). The cell lysates from the transfected 
cells were incubated with ubiquitin-agarose, and pull-down 
fractions were detected by immunoblotting with Flag antibody. 
As shown in Fig. 7 c, WT MCPIP1 was strongly associated with 
ubiquitin. MCPIP1C with deletion of the CCR and Pro 
region reduced the binding. MCPIP1N with deletion of the 
UBA abolished the binding with ubiquitin. These results sug-
gest that MCPIP1 contains a functional UBA and may medi-
ate the association of MCPIP1 with ubiquitinated proteins.
DISCUSSION
MCPIP1 (also known as ZC3H12A) is a prototype member 
of a novel CCCH Zn finger–containing protein family, which 
was originally identified as an MCP-1–induced gene in human 
peripheral monocytes through a DNA microarray (Zhou et al., 
2006). We previously found that MCPIP1 is a negative regu-
lator of proinflammatory activation of macrophages in vitro 
(Liang et al., 2008b). Recently, Matsushita et al. (2009) has 
identified ZC3H12A/MCPIP1 as an immune response mod-
ifier that has an essential role in preventing immune disorder 
through generating Zc3h12a KO mice. In this study, we inde-
pendently developed an Mcpip1/Zc3h12a-null mouse line. 
Disruption of Mcpip1 leads to severe inflammatory syndromes, 
including growth retardation, splenomegaly, lymphadenopa-
thy, and premature death. In the Mcpip1/ mice, inflamma-
tory cytokines, including TNF and MCP-1, were increased by 
>2.5-fold. BMDMs were more sensitive to LPS stimulation. 
contains a Pro-rich domain. By aligning the MCPIP1 se-
quences from different species, we further identified a con-
served region at N terminus (N-terminal conserved region 
[NCR]) just preceding CCCH Zn finger and another con-
served region at the C terminus (C-terminal conserved re-
gion [CCR]; Fig. 6 a).
To examine which domains are functionally important in 
deubiquitination, we generated serial truncated constructs of 
Flag-tagged MCPIP1 by PCR amplification of the indicated 
regions (Fig. 6 a). We cotransfected the truncated plasmids 
with HA-ubiquitin into HEK293 cells. Immunoblotting with 
HA antibody showed that WT MCPIP1 markedly decreased 
overall ubiquitination of cellular proteins. MCPIP1(1–555) 
and MCPIP1(81–599), with deletion of the UBA or CCR 
without affecting the NCR and Pro-rich domain, maintained 
similar deubiquitinating activity as WT MCPIP1. MCPIP1 
(1–453), with deletion of the Pro-rich domain, had lower 
deubiquitinating activity. MCPIP1(150–599), MCPIP1(150–
453), and MCPIP1(ZF) completely lost deubiquitinating 
activity (Fig. 6 b). These results suggest that NCR and CCCH 
Zn finger are critical for MCPIP1 deubiquitinating activity.
To further assess whether the repressor activity of MCPIP1 
on NF-B reporter is dependent on its deubiquitinating ac-
tivity, we cotransfected each truncated vector with reporter 
construct NF-B–TK-Luc into HEK293 cells. The trans-
fected cells were left untreated or treated with TNF for 24 h, 
followed by luciferase assays. As shown in Fig. 6 c, TNF in-
duced NF-B reporter activity by 12-fold. Expression of full-
length MCPIP1 repressed TNF-induced reporter activity 
by 80%. MCPIP1(1–555) and MCPIP1(81–599) main-
tained similar repressing activity as the full-length MCPIP1. 
MCPIP1(1–453) had lower repressor activity. MCPIP1(150–
599), MCPIP1(150–453), and MCPIP1(ZF) lost almost all 
of the repressor activity. These results suggest that the repres-
sor effect of MCPIP1 on NF-B signaling is dependent on its 
deubiquitinating activity.
The aforementioned results suggest that NCR and CCCH 
Zn finger may contain a novel DUB domain. As shown in 
Fig. 6 d, there are several putative Cys boxes and Asp boxes, 
which usually exist in Cys proteases, on the NCR of MCPIP1. 
To assess whether these putative boxes constitute the catalytic 
domain of MCPIP1 deubiquitinase, we generated serial point 
mutants of MCPIP1, as marked by asterisks in Fig. 6 d. The 
putative Cys box of MCPIP1 showed 39% sequence homol-
ogy with that of UCH-L1 and is conserved from fly to human 
(Fig. 6 e). Luciferase assay showed that the mutants with 
D141N, C157A, D278AD279A, and C306R totally lost the 
repressor activity on NF-B reporter (Fig. 6 f). Consistently, 
the purified protein with D141N, C157A, and C306R but 
not H88A also lost the deubiquitinating activity (Fig. 6 g). 
It was recently reported that MCPIP1 also has RNase activ-
ity, which targets to the IL-6 3 untranslated region (UTR). 
We also measured the RNase activity using these mutant pro-
teins. As shown in Fig. 6 h, MCPIP1 digested the IL-6 
3 UTR. Similar to a previous study (Matsushita et al., 2009), 
D141N mutant lost the RNase activity. However, H88A, 
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Figure 6. MCPIP1 contains a novel DUB domain. (a) The putative functional domains and conserved regions of MCPIP1 and the deletion strategy are 
shown. (b) HEK293 cells were cotransfected with HA-ubiquitin (Ub) and with the indicated MCPIP1 constructs. The overall ubiquitination of cellular pro-
teins was examined by immunoblot with HA-specific antibody. Results are representative of at least three independent experiments. (c) The influence of 
each MCPIP1 construct on NF-B reporter activity in TNF-stimulated HEK293 cells. Values are expressed as the fold increase in luciferase expression (±SD) 
compared with the vector alone (n = 4; *, P < 0.01 vs. MCPIP1(1–599) group). Results are representative of three independent experiments. (d) The puta-
tive Asp box and Cys box in the NCR are shown. Point mutants of MCPIP1 were generated as marked with asterisks. (e) Alignment of the Cys region of 
MCPIP1 with that from the UCH-L1 DUB domain. The NCBI Protein database accession numbers for human UCH-L1 and MCPIP1 of human, mouse, rat, 
zebrafish, and fly are P09936, NP_079355, NP_766373, NP_001071139, XP_001338688, and NP_650863, respectively. Red indicates completely conserved. 
Blue indicates mostly conserved. (f) The influence of each MCPIP1 construct on NF-B reporter activity in TNF-stimulated HEK293 cells. Values are ex-
pressed as the fold increase in luciferase expression (±SD) compared with the vector alone (n = 4; *, P < 0.01 vs. MCPIP1 WT group). Results are represen-
tative of three independent experiments. The expression of each construct was detected by immunoblot (IB) with anti-Flag antibody as shown.  
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and JNK signaling by selectively removing K63-linked poly-
ubiquitin chains from TRAFs, RIP, and NEMO, MCPIP1 
also cleaves K48-linked polyubiquitin chains in vitro. Another 
difference is that CYLD does not affect the global cellular 
ubiquitination. However, MCPIP1 markedly affects the overall 
ubiquitination of cellular proteins, which implies that MCPIP1 
may target more substrates and regulate multiple biological 
processes that need to be further identified. As evidence, 
MCPIP1/ mice showed much more complicated and se-
vere phenotypes than CYLD mutated mice (Jin et al., 2008).
The direct targets of MCPIP1 deubiquitinase in vivo are 
still uncertain. We observed that the ubiquitination of TRAF2, 
TRAF3, TRAF6, RIP, and IB was significantly decreased 
by MCPIP1 expression. Moreover, loss of Mcpip1 led to a drastic 
increase in basal and LPS-induced ubiquitination of TRAF2, 
TRAF3, and TRAF6 but not RIP. Because TRAF2 and TRAF6 
are upstream effectors of RIP and IB, the ubiquitination 
changes of RIP and IB caused by MCPIP1 expression may 
be indirect. MCPIP1 deubiquitinase may directly target to 
TRAF family members and regulate JNK and NF-B signal-
ing. At least we showed that the purified cellular ubiquitinated 
TRAF2 and TRAF3 can also be cleaved by MCPIP1 purified 
protein in vitro. Nevertheless, the direct targets of MCPIP1 
deubiquitinase in vivo need to be further characterized.
These results further support the idea that Mcpip1/Zc3h12a 
is a critical modulator of inflammatory response and immune 
homeostasis. How does MCPIP1 regulate inflammatory re-
sponse? Two groups recently reported that MCPIP1 might be 
functioning as an RNase to promote the degradation of some 
inflammatory mRNA such as IL-6 and IL-1 (Matsushita et al., 
2009; Mizgalska et al., 2009). In this study, we have found that 
MCPIP1 also acts as a deubiquitinase to negatively regulate 
JNK and NF-B signaling by targeting TRAFs, which sug-
gests that MCPIP1 may control inflammatory response and 
immune homeostasis by multiple mechanisms. Interestingly, 
TTP, another well-studied CCCH Zn finger–containing 
protein and a well-known RNA-destabilizing factor, was also 
reported to regulate NF-B signaling (Liang et al., 2009; Schichl 
et al., 2009).
Ubiquitination is a fundamental mechanism of signal 
transduction that regulates immune responses and many other 
biological processes (Sun, 2008). Similar to phosphorylation, 
ubiquitination is a reversible process that is counter-regulated 
by DUBs. Several DUBs such as CYLD, A20, DUBA, and 
Cezanne are involved in the regulation of inflammatory sig-
naling in macrophages and immune cells (Evans et al., 2003; 
Reiley et al., 2004; Wertz et al., 2004; Kayagaki et al., 2007). 
In contrast to CYLD and DUBA, which attenuate NF-B 
(g) Flag-tagged MCPIP1 proteins were purified from HEK293 cells and incubated with K63-linked Ub6 at 37°C for 16 h. The reactions were examined by 
immunoblotting with ubiquitin-specific antibody. The images of Coomassie blue–stained protein gel and immunoblot with anti-Flag are shown at the 
bottom. Results are representative of three independent experiments. HMUb, high molecular weight ubiquitin. (h) Flag-tagged MCPIP1 proteins were 
incubated with 32P-labeled transcripts from the IL-6 3 UTR at 30°C for 7 h. Samples were run on a 6% polyacrylamide–6M urea gel. The gels were dried 
and autoradiographed. The proteins loaded were detected by immunoblotting with anti-Flag as shown on the bottom. Two independent experiments 
showed similar results. (f–h) Vertical black lines indicate that intervening lanes have been spliced out. (i) HEK293 cells were transfected with control vec-
tor, Flag-MCPIP1, or Flag-C157A. After 24 h, the transfected cells were quiescent for 16 h and then stimulated with 100 ng/ml LPS for the indicated times. 
WCEs were subjected to immunoblot analysis with the antibodies as indicated. Two independent experiments showed similar results. (j) Mcpip1/ MEFs 
were transfected with Flag-MCPIP1 or Flag-C157A. After 24 h, the transfected cells and untransfected MEFs were stimulated with LPS for 5 h. TNF and 
MCP-1 in medium were measured by ELISA. Data are represented as mean ± SD (n = 3; *, P < 0.01). The expression of MCPIP1 constructs was detected by 
immunoblotting with anti-Flag as shown on the bottom.
 
Figure 7. MCPIP1 interacts with ubiquitin through the UBA at the N terminus. (a) The alignment of the putative UBA of MCPIP1 proteins from 
human, mouse, rat, zebrafish, and fly with UBA consensus sequence. Red indicates completely conserved amino acids. Blue indicates partially conserved 
amino acids. (b) HEK293 cells were transfected with Flag-tagged MCPIP1 and its C-terminal or N-terminal truncated mutants as indicated. (c) The cell 
lysates from transfected cells were incubated with ubiquitin-agarose and washed and analyzed by immunoblot with anti-Flag (pull-down). Input levels of 
each construct in the cell lysates were examined by immunoblot with anti-Flag. Results are representative of two independent experiments.
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critically important for its DUB activity. Although Asp141 is 
also important for its RNase activity, mutation of two other 
amino acids, C157A and C306R, that abolished DUB activity 
did not affect its RNase activity. In an NF-B reporter assay, 
the D141, C157, C306, and D278/D279 mutants resulted in 
the loss of MCPIP1 repressor activity on NF-B–dependent 
reporter activation. Furthermore, C157A mutant, which lost 
DUB activity but maintained RNase activity, also lost repres-
sor effect on JNK activation and LPS-induced inflammatory 
cytokine production. These results suggest that the inhibition 
of MCPIP1 on inflammatory signaling is dependent on its 
DUB activity. The relationship between the two enzymatic 
activities is under investigation.
There are many interesting questions that remain to be 
answered. How does MCPIP1 protein target to specific sub-
strates in response to environmental cues? We postulate that 
the specific adaptor proteins may recruit MCPIP1 to different 
substrates and exert different functions: degrading mRNA or 
cleaving polyubiquitin. In fact, MCPIP1 contains a single 
conserved CCCH ZF and a Pro-rich domain, which may 
mediate the interaction with adaptor proteins. There is also a 
functional UBA at the N terminus of MCPIP1. MCPIP1 
may interact with ubiquitinated protein through this domain. 
However, N-terminal truncation of MCPIP1 without this 
UBA also decreased protein ubiquitination in cells as WT 
MCPIP1, suggesting that this UBA may not be required for 
its DUB activity in vivo. MCPIP1 may also bind to its sub-
strates through other means. Nevertheless, identification of 
the binding partners of MCPIP1 will greatly enhance our 
understanding of MCPIP1 functions. In addition, it would be 
interesting to find out the function of the other three mem-
bers of the MCPIP1 family. In summary, we here identified 
MCPIP1 as a deubiquitinase that negatively regulates JNK 
and NF-B signaling by targeting TRAFs and defined a novel 
DUB domain, which suggests that MCPIP1 may control in-
flammation and immune response by multiple mechanisms 
and would be a potential therapeutic target for treatment of 
human inflammatory diseases.
MATERIALS AND METHODS
Generation of Mcpip1/ mice. The Mcpip1 targeting construct was built 
using the pN-Z-TK2 vector, which contains a nuclear LacZ cassette and a 
neomycin-resistance gene (provided by R. Palmiter, University of Washington, 
Seattle, WA). The 4.2-kb 5 arm and 2.7-kb 3 arm were amplified by PCR 
using a BacPac vector (RP23-262L9) as template, which was from C57BL/6 
mice and contained the Mcpip1 gene. The amplified DNA fragments were 
confirmed by sequencing and inserted upstream and downstream of the 
nuclear LacZ-Neo cassette by KpnI–SalI and XhoI–NotI, respectively. The 
targeting construct was linearized and electroporated into C57BL/6-derived 
embryonic stem cells (inGenious Targeting Laboratory, Inc.). After selection 
with G418, drug-resistant clones were picked up and screened by PCR and 
Southern blot analysis. Two Mcpip1-targeted embryonic stem clones were 
individually microinjected into blastocysts derived from C57BL/6 mice and 
transferred to pseudopregnant females. The resulting chimeric mice were 
bred to C57BL/6 to obtain germline transmission of the mutant allele. 
Resulting Mcpip1+/ mice were intercrossed to generate Mcpip1/ mice. All 
animal experiments were performed with the approval of the institutional 
animal care and use committee at the University of Central Florida.
MCPIP1 may selectively regulate different signal path-
ways. As shown in our results, MCPIP1 is a potent suppressor 
of both LPS- and IL-1–induced JNK activation. However, 
MCPIP1 just moderately affects LPS-induced IKK activation 
but does not affect IL-1–induced IKK activation. This is 
consistent with the other observation that ubc13, a unique E2 
for K63-linked ubiquitination, is essential for JNK activation 
but not critical for NF-B activation (Yamamoto et al., 2006). 
Interestingly, overexpression of MCPIP1 potently suppresses 
LPS- and cytokine-induced NF-B–dependent reporter activ-
ity. It suggests that MCPIP1 may also target the downstream 
effectors of NF-B signaling. Matsushita et al. (2009) did not 
find any difference between Mcpip1/ and Mcpip1+/+ mice 
with respect to LPS-induced NF-B and AP-1 activation in 
peritoneal macrophages. The reason for this discrepancy is not 
yet known but may be caused by the different cell types used. 
In the lung from Mcpip1/ mice, both JNK and IKK were 
constitutively activated. However, JNK and IKK in BMDMs 
were not constitutively activated; instead, their activation was 
enhanced by LPS stimulation. The reason for this difference 
may be because there are many mature macrophages in the 
lung and these macrophages are exposed to the air.
The human genome encodes almost 100 DUBs (Nijman 
et al., 2005). Based on their domain structures, these DUBs 
can be divided into five families: UCHs, ubiquitin-specific 
proteases, otubain proteases, Machado-Joseph disease prote-
ases, and JAB1/PAB1/MPN domain–containing metalloen-
zymes. Each contains specific but conserved DUB domains. 
MCPIP1 does not belong to any of the five known families 
as it does not contain any of the five specific domains based 
on sequence alignment. However, we characterized the NCR 
containing intrinsic deubiquitinating activity, which has re-
mote sequence homology to the UCH domain (27%). In ad-
dition, MCPIP1 contains two conserved sequence motifs, the 
Cys and Asp boxes, in its catalytic domain, which is common 
in Cys proteases. Mutation of several histidines did not impair 
the deubiquitinating activity, suggesting that the His box may 
be located outside of the NCR or that MCPIP1 lacks the His 
box as does CYLD. Some of the biochemical characteristics 
of DUB of MCPIP1 are similar to other DUBs. Its deubiqui-
tinating activity can be completely abolished by NEM, a Cys 
protease inhibitor, which is consistent with MCPIP1 being 
a Cys protease. In addition, the deubiquitinating activity of 
MCPIP1 is not dependent on Mg2+ and ATP but is inhibited 
by Zn2+ and Mn2+, as reported for another DUB (Matsui et al., 
1982). Thus, MCPIP1 may represent a member of a novel 
DUB family.
It was recently reported that MCPIP1 has RNase activity 
and may control immune response through regulating in-
flammatory mRNA decay (Matsushita et al., 2009). In this 
study, we provide evidence that MCPIP1 also acts as a DUB 
to negatively regulate inflammatory signaling. By deletion 
experiments, MCPIP1 deubiquitinase domain has also been 
mapped on NCR regions as its RNase domain. However, se-
rial mutagenesis showed that Asp141, Cys157, and Cys306 in 
the Asp box, Cys box, and CCCH Zn finger, respectively, are 
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SDS-PAGE and analyzed by immunoblotting with Flag, HA, or MCPIP1 
antibodies. Membranes were developed with enhanced chemiluminescence 
(GE Healthcare).
RNA isolation, RNA blot, and quantitative PCR (QPCR). Total 
RNA was isolated from cells or tissues using RNA STAT-60 reagent (Tel-
Test, Inc.) according to the manufacturer’s instruction. RNA blot and QPCR 
were performed as described previously (Liang et al., 2008b).
In vivo deubiquitination assay. HEK293 cells were transfected with HA-
ubiquitin as well as other plasmids as indicated. 24 h later, cells were stimu-
lated with TNF for 2 h, and the cells were harvested using RIPA buffer 
(Thermo Fisher Scientific) containing protease inhibitor cocktail, 20 µM 
NEM, and 2 µM ubiquitin aldehyde. The whole cell extracts (WCEs) were 
directly subjected to immunoblot analysis with HA antibody or further im-
munoprecipitated using specific antibodies as indicated and then analyzed by 
immunoblot with HA antibody.
Purification of Flag-MCPIP1 and its mutant proteins. Flag-MCPIP1 
or its mutants were transfected into HEK293 cells individually. 48 h later, the 
transfected cells were harvested using RIPA buffer containing protease in-
hibitor cocktail. The cell lysates were incubated with Flag M2 beads (Sigma-
Aldrich) overnight with rotation at 4°C. After washing three times, the 
Flag-MCPIP1 was eluted by 3xFlag elution buffer.
Cell-free deubiquitination assay. 0.5 µg K48- or K63-linked ubiquitin 
chains (Boston Biochem) were mixed with purified Flag-MCPIP1 or its mutant 
proteins in DUB assay buffer (50 mM Hepes-NaOH, pH 8.0, 10% glycerol, 
and 3 mM DTT) at 37°C for 16 h or the indicated times. Samples were pre-
pared for immunoblot analysis with ubiquitin antibody (Boston Biochem).
In vitro cleavage assay of cellular ubiquitinated TRAFs. Flag-TRAF2 
or Flag-TRAF3 was cotransfected with HA-ubiquitin into HEK293 cells. 24 h 
later, the transfected cells were stimulated with TNF for 15 min. The cells 
were harvested using RIPA buffer containing protease inhibitor cocktail and 
NEM. The cell lysates were incubated with Flag M2 beads overnight with 
rotation at 4°C. After washing three times with TBS buffer, Flag-TRAF2 or 
Flag-TRAF3 was eluted by 3xFlag elution buffer. 15 µl of eluted Flag-
TRAF2 or Flag-TRAF3 was incubated with purified Flag-MCPIP1 in 
DUB assay buffer at 37°C for 4 h. Samples were prepared for immunoblot 
analysis with HA and Flag antibodies.
In vitro RNA cleavage assay. The pTOPO–IL-6 3 UTR (1–430) plas-
mid was used as a template for the synthesis of RNA having an IL-6 3 UTR 
sequence. In vitro RNA synthesis and 32P labeling were performed using the 
Riboprobe in vitro transcription system (Promega) according to the manu-
facturer’s instructions. Equal amounts of in vitro transcribed 32P-labeled 
RNAs (5,000 cpm) were incubated with 2 µg MCPIP1 or its mutants at 
30°C for 7 h in 25 mM Hepes, pH 8.0, 50 mM potassium acetate, 5 mM 
DTT, and 5 mM Mg acetate. The cleaved RNA was purified with TRIZOL 
(Invitrogen). Samples were run on a 6% polyacrylamide–6M urea gel in 1× Tris/
Borate/EDTA buffer after RNA sample buffer and loading buffer were added 
to the samples, and samples were heated at 80°C for 10 min according to the 
manufacturer’s recommendations. Gels were dried and autoradiographed.
Ubiquitin chain binding assay. Flag-MCPIP1 and its mutant proteins 
purified from HEK293 cells were incubated with ubiquitin-agarose (Boston 
Biochem) in 50 mM Tris-HCI, pH 7.5, 150 mM NaCl, and 1% Triton buffer 
overnight at 4°C. Immunoprecipitants were washed with the same buffer for 
three times and subjected to immunoblot analysis with Flag antibody.
Statistics. Data were expressed as mean ± SD. For comparison between two 
groups, the unpaired Student’s t test was used. For multiple comparisons, 
analysis of variance followed by unpaired Student’s t test was used. A value of 
P < 0.05 was considered significant.
Cells. The mouse macrophage cell line RAW264.7 was obtained from the 
American Type Culture Collection and maintained in RPMI 1640 supple-
mented with 2 mM Gln, 100 U/ml penicillin and streptomycin, and 10% 
FBS (endotoxin <1 ng/ml; Sigma-Aldrich). HEK293 cells were cultured in 
DME supplemented with 2 mM Gln, 100 U/ml penicillin and streptomycin, 
and 10% FBS. Mouse BMDMs were generated from BM stem cells obtained 
from femurs of the male Mcpip1+/+ and Mcpip1/ mice (6 wk old). After lysis 
of the red blood cells, 4 × 106 of BM stem cells were inoculated in a 6-well 
plate with complete DME culture medium containing 10% FBS, 30% 
L-medium, and standard supplements. After 5-d culture, the fully differentiated 
and matured BMDMs were quiescent for 24 h in macrophage serum-free 
medium and then treated with 100 ng/ml LPS for different time points.
Plasmids. NF-B–TK-Luc, AP-1–TK-Luc, and GAS-TK-Luc were pur-
chased from Agilent Technologies. Flag-TRAF2 plasmid was provided by 
Y. Sun (University of Michigan, Ann Arbor, MI). Flag-TRAF3 plasmid was 
provided by G. Chen (University of California, Los Angeles, Los Angeles, CA). 
Flag-TTP was provided by J. Lykke-Andersen (University of California, 
San Diego, La Jolla, CA). HA-ubiquitin was obtained through Addgene from 
T. Dawson (Johns Hopkins University, Baltimore, MD). MCPIP1-GFP 
plasmid was described previously (Zhou et al., 2006; Liang et al., 2008b). 
HA-tagged MCPIP1 expression plasmid was generated by inserting human 
MCPIP1 coding fragment into pcDNA3-HA vector at EcoRI and XbaI 
sites. Flag-tagged MCPIP1 expression plasmid was generated by inserting 
human MCPIP1 coding fragment into pCMV-MAT-Tag-Flag-1 vector 
(Sigma-Aldrich) at HindIII and BamHI sites. MCPIP1 serial deletion plas-
mids were generated by inserting the PCR-amplified fragments into pCMV-
MAT-Tag-Flag-1 vector at EcoRI and XbaI sites. MCPIP1ZF plasmid was 
generated by mutating K311C312 into GG using Flag-MCPIP1 as template. 
MCPIP1 serial point mutants were generated using the QuikChange II Site-
Directed Mutagenesis kit (Agilent Technologies) using Flag-MCPIP1 as 
template. IL-6 3 UTR (1–403) was amplified by PCR and inserted into 
pCR-Blunt II-TOPO (Invitrogen).
Reagents. The MCPIP1 rabbit polyclonal antibody was prepared against the 
human recombinant MCPIP1 protein as described previously (Zhou et al., 
2006; Liang et al., 2008b). Except antiubiquitin antibody from Boston Bio-
chem, all other antibodies used in this paper were purchased from Cell Sig-
naling Technology. Anti-Flag M2 affinity gel, anti-HA immunoprecipitation 
kit, protein G immunoprecipitation kit, LPS (Escherichia coli 026:B6-derived), 
human recombinant IFN-, IL-1, and TNF, NEM, and other chemical re-
agents were purchased from Sigma-Aldrich. Ubiquitin chains, ubiquitin-
AFC, ubiquitin-agarose, IsoT, ubiquitin aldehyde, and MG132 were purchased 
from Boston Biochem. Purified Flag-BAP, an N-terminal Flag fusion protein 
of E. coli BAP, was purchased from Sigma-Aldrich.
Transient transfection and luciferase assay. Transfection and luciferase 
assay were performed as described previously (Liang et al., 2008b). All trans-
fections were performed in triplicate and repeated at least two times.
Protein isolation and immunoblotting. Protein isolation and immunob-
lotting were essentially performed as described previously (Liang et al., 
2008b). To facilitate the detection of the phosphorylated or ubiquitinated 
proteins in cell lysates, radioimmunoprecipitation assay (RIPA) buffer was 
added with protease inhibitor cocktails (Sigma-Aldrich), phosphatase cock-
tail I and II (Sigma-Aldrich), 20 µM NEM, and 2 µM ubiquitin aldehyde.
Coimmunoprecipitation. For endogenous immunoprecipitations, the 
transfected HEK293 cells were lysed in CelLytic M Cell lysis buffer with 
protease inhibitors, phosphatase inhibitors, NEM, and ubiquitin aldehyde. 
Lysates were incubated with specific antibodies. The immune complexes 
were collected by incubation (2 h at 4°C) with protein G–agarose (Sigma-
Aldrich). Coimmunoprecipitation assays were performed by using anti-Flag 
matrix (Sigma-Aldrich) according to the manufacturer’s instruction. After 
extensive washing, immunoprecipitated proteins were resolved by 6–10% 
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